Opinion: Shortages of generic drugs can’t be blamed solely on group purchasing organizations
STAT
APRIL 25, 2024
More than 90% of prescriptions filled that year were for generics or biosimilars, up from just over 18% the year that Hatch-Waxman was passed. The Hatch-Waxman Act of 1984, which gave rise to the modern generic drug market, was one of the most significant cost-reducing policy innovations of the last 40 years.
Let's personalize your content